BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2016
View Archived Issues
FAK inhibition shows potential as a target for combination with immunotherapy
Read More
miR-1246 and miR-1290 as novel therapeutic targets and biomarkers of disease progression
Read More
University of Vermont and State Agricultural College patents autophagy inhibitors
Read More
Auspex Pharmaceuticals discloses cytochrome P450 CYP11B1 inhibitors
Read More
Novira Therapeutics describes antiviral agents
Read More
Madrigal Pharmaceuticals, Synta Pharmaceuticals complete merger
Read More
EMA committee recommends approval of Onivyde in E.U.
Read More
EMA's CHMP grants positive opinion to Cabometyx in RCC
Read More
XBiotech reports progress for Xilonix in U.S. and E.U.
Read More
EMA committee supports approval of Eisai's Kisplyx
Read More
Euroscreen opens IND for three phase II studies of ESN-364
Read More
IDO activity shows promise as a biomarker for tuberculosis
Read More
FDA grants QIDP and fast track designations to MCB-3837 for C. difficile infection
Read More
Roche updates pipeline progress of second quarter 2016
Read More
Increased sCD74 serum levels correlate with severity of lung injury
Read More
miR-877-3p as a potential new fibrosis marker for predicting prognosis
Read More
Functional rs353292 polymorphism in the flanking region of miR-143/145 as risk factor for CRC
Read More
InflaRx raises funds in series C financing
Read More
VIB and Oxford Nanopore Technologies collaborate on DNA sequencing technology
Read More
Almirall and Patagonia Pharmaceuticals enter licensing agreement
Read More
EMA's CHMP adopts positive opinion on type II variation application for Gilead's Truvada
Read More
Grant supports work at The Scripps Research Institute on stem cells for Parkinson's disease
Read More
Sunovion reports results of SUN-101/eFlow phase III study
Read More